Details of the Drug

General Information of Drug (ID: DMJLNZQ)

Drug Name
K-828-AB
Synonyms GABA transaminase inhibitor (oral, dementia), Kowa
Indication
Disease Entry ICD 11 Status REF
Dementia 6D80-6D86 Phase 2 [1]
Cross-matching ID
TTD ID
D0YC4F

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA transaminase (ABAT) TTT2LD9 GABT_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Kowa Co Ltd.
2 Phase II clinical trial of K-828-AB for treating behavioral and psychological symptoms of dementia. Kowa Co. Ltd.